Your session is about to expire
← Back to Search
Letrozole + Clomiphene Citrate for Anovulation (CLC II Trial)
CLC II Trial Summary
This trial is testing whether adding clomiphene citrate to letrozole helps treat infertility in women with polycystic ovary syndrome.
CLC II Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCLC II Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 4 trial • 79 Patients • NCT02137538CLC II Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have high prolactin levels that haven't been treated.I am willing and able to follow all study rules and attend all appointments.I have been diagnosed with polycystic ovary syndrome.I am currently using hormonal birth control methods.I haven't taken medication that affects fertility or metabolism in the last month.I have a known cause of infertility such as endometriosis, tubal issues, or uterine abnormalities.I can have regular intercourse during the study's ovulation phase.I have a thyroid condition that hasn't been treated.My partner and I have been unable to conceive despite trying for a specific period.I have been unable to get pregnant after trying for the required time based on my age.I cannot take clomiphene citrate or letrozole due to health reasons.I can have regular sexual intercourse during the study's ovulation phase.If you are a man, you need to have a certain amount of healthy sperm or have fathered a pregnancy before.My partner has normal sperm or has fathered a child before.If you have uncontrolled diabetes or high blood pressure, it's better to wait until they are under control before getting pregnant.You have been diagnosed with polycystic ovary syndrome based on specific medical criteria.
- Group 1: Letrozole + Clomiphene Citrate
- Group 2: Letrozole
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this investigation accepting participants who are over sixty years of age?
"The age criteria for this research trial necessitates that all participants must be between 18 and 40 years of age."
What qualifications are necessary to qualify for this medical experiment?
"This medical trial is looking to recruit 184 individuals grappling with infertility, whose age falls between 18 and 40. The criteria for participation are as follows: a period of 12 months without successful pregnancy following regular unprotected intercourse (for those under 35) or 6 months without contraception use (if over 35); anovulation/oligomenorrhea; capacity for consistent sexual activity during the ovulatory induction phase; partner's sperm concentration at 15 million/mL with motility exceeding 40% per World Health Organization cutoffs, or total motile count higher than 10 mil.; and finally, willingness to comply with all study procedures throughout its duration."
How many individuals have enrolled in this research project so far?
"Affirmative. Per the clinicaltrials.gov website, this research study is actively recruiting participants which began on October 26th 2020 and was recently updated on January 24th 2022. A total of 184 volunteers are sought from two different medical facilities."
Are there any open slots for enrollment in this clinical trial?
"Affirmative. Clinicaltrials.gov data displays that this clinical trial, which commenced on October 26th 2020, is actively looking for new participants. A total of 184 individuals must be recruited from 2 distinct locations to complete the study."
What side effects have been reported in patients taking Letrozole?
"Our team at Power assessed the safety of Letrozole to be a 3 since this is an approved Phase 4 trial, signifying that there is ample evidence attesting its efficacy."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger